Real-world data on the use of cannabidiol in patients with Lennox-Gastaut Syndrome or Dravet Syndrome in the UK early access programme

被引：0
|
作者：
Saravanai-Prabu, S. [1 ]
Eltze, C. [2 ]
Alshehhi, S. [2 ]
Al Ghfeli, A. [2 ]
Vyas, K. [1 ]
Gusto, G. [3 ]
Khachatryan, A. [4 ]
Martinez, M. [5 ]
Desurkar, A. [6 ]
机构：
[1] Jazz Pharmaceut Inc, London, England
[2] Great Ormond St Hosp Sick Children, London, England
[3] Certara, Paris, France
[4] Certara, London, England
[5] Certara, Madrid, Spain
[6] Sheffield Childrens NHS Fdn Trust, Sheffield, England
来源：
EPILEPSIA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1486
引用
收藏
页码：517 / 517
页数：1
相关论文
共 50 条
  • [41] Diarrhoea in patients with Lennox-Gastaut Syndrome (LGS) or Dravet Syndrome (DS) enrolled in four phase 3 Clinical Trials of Cannabidiol (CBD)
    Nabbout, Rima
    Bhathal, Hari
    Zolnowska, Marta
    Sidhu, Meneka
    Li, Jie
    Hyland, Kerry
    Nortvedt, Charlotte
    EPILEPSIA, 2021, 62 : 273 - 274
  • [42] Early Diagnosis and Treatment of Lennox-Gastaut Syndrome
    Resnick, Trevor
    Sheth, Raj D.
    JOURNAL OF CHILD NEUROLOGY, 2017, 32 (11) : 947 - 955
  • [43] Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
    Laux, Linda C.
    Bebin, E. Martina
    Checketts, Daniel
    Chez, Michael
    Flamini, Robert
    Marsh, Eric D.
    Miller, Ian
    Nichol, Kathryn
    Park, Yong
    Segal, Eric
    Seltzer, Laurie
    Szaflarski, Jerzy P.
    Thiele, Elizabeth A.
    Weinstock, Arie
    Beal, Jules C.
    Comi, Anne M.
    Devinsky, Orrin
    Joshi, Charuta
    Lopez, Merrick
    Lyons, Paul D.
    Patel, Anup D.
    Wechsler, Robert
    Wong, Matthew H.
    Zentil, Pilar Pichon
    EPILEPSY RESEARCH, 2019, 154 : 13 - 20
  • [44] Review of stiripentol use in Lennox-Gastaut syndrome
    Chancharme, L.
    Serraz, B.
    Bar, C.
    EPILEPSIA, 2024, 65 : 220 - 220
  • [45] Cannabidiol (CBD) in patients with Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS) on a Ketogenic Diet Therapy (KDT) in four phase 3 trials
    Cross, J. Helen
    Vyas, Kishan
    Sahebkar, Farhad
    Schreiber, Ashley
    Mazurkiewicz-Beldzinska, Maria
    EPILEPSIA, 2021, 62 : 269 - 270
  • [46] Time to Onset of Efficacy of Cannabidiol (CBD) During Titration in Patients with Lennox-Gastaut Syndrome and Dravet Syndrome Enrolled in Three Randomized Controlled Trials
    Mazurkiewicz-Beldzinska, Maria
    Privitera, Michael
    Marsh, Eric
    Villanueva, Vicente
    VanLandingham, Kevan
    Checketts, Daniel
    Knappertz, Volker
    NEUROLOGY, 2019, 92 (15)
  • [47] Pharmacokinetics of rufinamide in patients with Lennox-Gastaut syndrome
    Fuseau, E.
    Critchley, D.
    Arroyo, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 209 - 209
  • [48] Time To Onset Of Efficacy Of Cannabidiol (CBD) During Titration In Patients With Lennox-Gastaut Syndrome Or Dravet Syndrome Enrolled In Three Randomised Controlled Trials
    Mazurkiewicz-Beldzinska, M.
    Privitera, M.
    Marsh, E.
    Villanueva, V.
    VanLandingham, K.
    Checketts, D.
    Knappertz, V.
    EPILEPSIA, 2019, 60 : 64 - 64
  • [49] Clobazam for patients with Lennox-Gastaut syndrome and epilepsy
    Seif-Eddeine, Hussam
    Ng, Yu-Tze
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 385 - 393
  • [50] Surgical options for patients with Lennox-Gastaut syndrome
    Douglass, Laurie M.
    Salpekar, Jay
    EPILEPSIA, 2014, 55 : 21 - 28
12345